Clinical Trial Update: Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining cytotoxic CD8 T cell responses after Yellow Fever YF-17D vaccination in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• Yellow fever vaccine (YF-17D) (YF-17D yellow fever vaccine)

Snippet

Sponsor: University of Aarhus | Conditions: Healthy, Cytotoxicity | Phase 4 | Status: ACTIVE_NOT_RECRUITING